BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 20, 2006
View Archived Issues
Imidacrine acts as potent, selective FLT3 inhibitor
Read More
Studies identify effective sedative doses of Aquavan
Read More
Combined data show superiority of aprepitant in postoperative nausea and vomiting
Read More
Human thrombin shows noninferiority to bovine thrombin in general surgery
Read More
VGX completes manufacturing of VGX-150 drug product for clinical trials
Read More
Australian orphan drug designation for Genasense in melanoma
Read More
Lexicon begins IND-enabling studies for LX-2931
Read More
IL-21 studied in combination with Nexavar for kidney cancer
Read More
Rigel selects R-348 for advanced preclinical development
Read More
Positive preclinical findings for Apollo's topical psoriasis treatment
Read More
Martek's DHA selected for NIH Alzheimer's study
Read More
RX-0201 completes phase I trials
Read More
SBIR funding for Lentigen's work targeting mesothelin
Read More
SB-15 advancing for anxiety associated with fragile X syndrome, autism
Read More
KN-38-7271 to begin phase II trial in traumatic brain injury
Read More
Depomed obtains sublicense for gabapentin in menopausal hot flashes
Read More
Sativex filed in Canada for cancer pain
Read More
Replagal approved for children from seven years with Fabry's disease in Europe
Read More
Remicade approved for maintenance therapy in ulcerative colitis
Read More
Sanofi-aventis objects to German reimbursement recommendation for Acomplia
Read More
Gleevec approved for five rare disorders
Read More
Elaprase recommended for European approval in Hunter's syndrome
Read More
DOV-51892 shows higher potency than diazepam at activating the GABA-A1 receptor
Read More
A-582941's therapeutic potential profiled at the Society for Neuroscience meeting
Read More
Abbott reports on the broad analgesic properties of their new selective CB2 agonist
Read More
MEM-1003's cardiovascular safety profile may be due to weaker antagonism of the Cav1.2 channel
Read More
Yakuchinone analogues possess antineurotoxic properties
Read More
Recent BiRDS Pharma patent describes new therapeutic agents for muscle spasm
Read More
Novel agents for asthma, chronic obstructive pulmonary disease, etc., described
Read More
Recent patents claim novel antiulcer, anti-HCV agents
Read More
